Acquisitions7 Feb 2026, 06:41 pm
Entero Healthcare Completes Majority Stake Acquisition in Anand Chemiceutics
AI Summary
Entero Healthcare Solutions Ltd has completed the acquisition of a 51.51% majority equity stake in Anand Chemiceutics Private Limited. This announcement follows a previous intimation dated November 12, 2025, where the company had disclosed the details of the acquisition as per Regulation 30 and SEBI Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024. This development is a significant step in Entero Healthcare's growth strategy and is expected to strengthen its presence in the market.
Key Highlights
- Entero Healthcare Solutions Ltd has completed the acquisition of a 51.51% majority equity stake in Anand Chemiceutics Private Limited.
- The acquisition details were previously disclosed as per Regulation 30 and SEBI Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024.
- This acquisition is a significant step in Entero Healthcare's growth strategy.
- The acquisition is expected to strengthen Entero Healthcare's presence in the market.